Amicus Therapeutics, Inc. Stock
Stocks
FOLD
US03152W1099
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.49 USD | +0.21% |
|
-.--% | +1.76% |
| 05-05 | BioMarin Enters 'Transition Year' as Enzyme Portfolio Expands After Amicus Deal, Morgan Stanley Says | MT |
| 04-28 | Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P Global BMI Index | CI |
| Market Cap | 4.55B 3.93B 3.62B 3.39B 6.35B 432B 6.45B 42.76B 16.67B 210B 17.08B 16.71B 729B | P/E Ratio 2024 |
-51.1x | P/E Ratio 2025 | -162x |
|---|---|---|---|---|---|
| Enterprise Value | 4.7B 4.06B 3.74B 3.5B 6.56B 447B 6.66B 44.16B 17.22B 217B 17.63B 17.26B 753B | EV / Sales 2024 |
5.69x | EV / Sales 2025 | 7.18x |
| Free-Float |
99.31% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Amicus Therapeutics, Inc.
| 1 day | +0.21% | ||
| 3 months | +0.84% | ||
| 6 months | +46.36% | ||
| Current year | +1.76% |
| Current year | 14.2 |  | 14.5 |
| 1 year | 5.51 | | 14.5 |
| 3 years | 5.51 | | 14.57 |
| 5 years | 5.51 | | 14.57 |
| 10 years | 4.41 | | 25.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Davis
PSD | President | 55 | 2026-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-26 | Issuer sale | General Counsel | 1,264,993 | 0.4029% | ||
| 04-26 | Issuer sale | Director | 398,261 | 0.1268% | ||
| 04-26 | Issuer sale | Director | 395,940 | 0.1261% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | -.--% | +135.99% | +13.11% | 4.55B | |
| -0.35% | -0.22% | -15.03% | -12.88% | 42.96B | |
| +3.11% | +3.11% | +274.29% | +507.94% | 31.73B | |
| +0.22% | -1.08% | +14.03% | -14.37% | 30.22B | |
| +1.62% | -2.08% | -4.36% | +24.05% | 28.94B | |
| +4.09% | -1.98% | +11.99% | +17.37% | 23.87B | |
| -1.63% | +2.88% | +53.73% | +114.36% | 13.57B | |
| -0.40% | -1.48% | +7.48% | +7.12% | 12.96B | |
| +1.14% | +3.62% | - | - | 13.39B | |
| -0.74% | -1.62% | +105.71% | +76.01% | 12.2B | |
| Average | +0.59% | -0.62% | +64.87% | +81.41% | 21.44B | |
| Weighted average by Cap. | +0.79% | -1.05% | +56.60% | +93.88% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 528M 456M 420M 394M 738M 50.21B 749M 4.96B 1.94B 24.44B 1.98B 1.94B 84.63B | 634M 548M 505M 472M 885M 60.28B 899M 5.96B 2.32B 29.34B 2.38B 2.33B 102B |
| Net income | -56.11M -48.46M -44.65M -41.8M -78.33M -5.33B -79.55M -527M -206M -2.6B -211M -206M -8.99B | -27.11M -23.41M -21.58M -20.2M -37.85M -2.58B -38.44M -255M -99.33M -1.25B -102M -99.58M -4.34B |
| Net Debt | 194M 167M 154M 144M 270M 18.41B 275M 1.82B 710M 8.96B 727M 711M 31.03B | 149M 129M 118M 111M 208M 14.15B 211M 1.4B 545M 6.89B 559M 547M 23.84B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- FOLD Stock
Select your edition
All financial news and data tailored to specific country editions
